Strata Critical Medical Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Strata Critical Medical Inc in the third quarter 2026?
Strata Critical Medical Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter 2026, resulting in a negative return on equity (ROE) of -8.86%.

Within the Medical Equipment & Supplies industry 21 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 707 to 780.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	-2.34 %	25.2 %	30.04 %	25.74 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-25	40	47	41	40
Return On Equity (TTM)	-8.86 %	14.27 %	17.55 %	16.46 %	17.05 %
SRTA's Total Ranking	# 780	# 707	# 720	# 725	#
Equity (TTM) in Millions	276	279	286	279	283
Seq. Equity Change	-1.05 %	-2.24 %	2.39 %	-1.39 %	26.85 %
Seq. Net Income Change	-	-	-	-	-

Back to SRTA Management Effectiveness >> SRTA's 5 Years Annual ROE >> Compare SRTA ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 22
Sector	# 99
Overall	# 780

Return On Equity Statistics
High	Average	Low
17.55 %	-45.76 %	-443.51 %
(Mar 31 2026)		(Mar 31 2021)

SRTA Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Sep 30 2021) 2021
Total Equity in Millions	279	222	234	274	291
Y / Y Equity Change	25.74 %	-5.28 %	-14.64 %	-5.75 %	5724.57 %
Net Income in Millions	41	-27	-56	-27	-40
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	14.82 %	-12.3 %	-23.93 %	-9.93 %	-13.75 %

Back to SRTA Management Effectiveness >> SRTA's 5 Years Annual ROE >> Compare SRTA ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 14.82 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
SRTA's' Return on Equity at Yahoo Finance
SRTA's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for SRTA's Competitors
Subscribers only: Roe for Strata Critical Medical Inc 's Suppliers
Subscribers only: Return On Equity for SRTA's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector

ROE

Date modified: 2026-11-04T15:26:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.